SCHEMBL27697134

SCHEMBL27697134

O=C1NC(=O)c2cc(Nc3ccc(F)cc3)ccc21

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.72
KMT2A Q03164 4/20 0.72
PRKD3 O94806 3/20 0.72
PRKCG P05129 3/20 0.72
PRKCB P05771 3/20 0.72
SRC P12931 3/20 0.72
PRKCA P17252 3/20 0.72
PRKCH P24723 3/20 0.72
PRKCI P41743 3/20 0.72
PRKCE Q02156 3/20 0.72
PRKCQ Q04759 3/20 0.72
PRKCZ Q05513 3/20 0.72
PRKCD Q05655 3/20 0.72
PRKD1 Q15139 3/20 0.72
MEN1 O00255 3/20 0.72
MAPT P10636 2/20 0.72
TDP1 Q9NUW8 2/20 0.72
GRM5 P41594 2/20 0.56
CASP3 P42574 1/20 0.54
MAOA P21397 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27369690 0.84 EGFR (0.68) EGFRKMT2APRKD3PRKCGPRKCB
Cgp-53353 SCHEMBL29766901 0.84 EGFR (1.00) EGFRKMT2APRKD3PRKCGPRKCB
Cgp-53353 SCHEMBL230492 0.84 EGFR (1.00) EGFRKMT2APRKD3PRKCGPRKCB
SCHEMBL9566653 0.82 KMT2A (0.49) EGFRKMT2APRKD3PRKCGPRKCB
SCHEMBL10600683 0.82 PPOX (0.69) EGFRKMT2APRKD3PRKCGPRKCB
SCHEMBL9566667 0.82 APP (0.61) EGFRKMT2APRKD3PRKCGPRKCB
SCHEMBL22032609 0.79 MAPT (0.54) EGFRKMT2APRKD3PRKCGPRKCB
SCHEMBL29535893 0.78 GRM5 (0.63) EGFRKMT2APRKD3PRKCGPRKCB
SCHEMBL1953630 0.78 GRM5 (0.63) EGFRKMT2APRKD3PRKCGPRKCB
SCHEMBL10423465 0.77 PPOX (0.47) EGFRKMT2APRKD3PRKCGPRKCB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110290800-A Conjugating biomolecules, medical composition and method 台湾浩鼎生技股份有限公司 2019-09-27 CN disclosed
CN-107794302-A Determine method of the cancer to EGF-R ELISA magnetic target therapy reactivity 综合医院公司 2018-03-13 CN disclosed
CN-102586431-A Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments GEN HOSPITAL CORP 2012-07-18 CN disclosed
CN-101501211-A Method for Determining Responsiveness of Cancer to Epidermal Growth Factor Receptor Targeted Therapy GEN HOSPITAL CORP (US) 2009-08-05 CN disclosed
CN-101084015-A Antibody formulations in histidine-acetate buffer GENENTECH INC (US) 2007-12-05 CN disclosed